NEXT Financial Group, Inc - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 47 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
NEXT Financial Group, Inc ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$3,000
-50.0%
1,0000.0%0.00%
-66.7%
Q3 2018$6,000
+100.0%
1,0000.0%0.00%
+200.0%
Q3 2017$3,000
-99.8%
1,0000.0%0.00%
Q2 2017$2,000,000
-33.3%
1,0000.0%0.00%
-100.0%
Q1 2017$3,000,000
+200.0%
1,0000.0%0.00%
Q4 2016$1,000,000
+99900.0%
1,0000.0%0.00%
Q3 2016$1,0001,0000.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$401,0000.10%
Geneos Wealth Management Inc. 511,606$2,261,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$26,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 18,967$41,0000.01%
Vivaldi Capital Management LP 10,668$45,0000.01%
OSAIC HOLDINGS, INC. 1,221,984$2,651,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$34,0000.00%
WEDBUSH SECURITIES INC 17,998$39,0000.00%
D.A. DAVIDSON & CO. 65,310$142,0000.00%
Virtu Financial LLC 14,683$32,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders